JP2021511388A5 - - Google Patents

Info

Publication number
JP2021511388A5
JP2021511388A5 JP2020561603A JP2020561603A JP2021511388A5 JP 2021511388 A5 JP2021511388 A5 JP 2021511388A5 JP 2020561603 A JP2020561603 A JP 2020561603A JP 2020561603 A JP2020561603 A JP 2020561603A JP 2021511388 A5 JP2021511388 A5 JP 2021511388A5
Authority
JP
Japan
Prior art keywords
skin
ceramide
reduce
composition according
appearance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020561603A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021511388A (ja
JP7369716B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/015137 external-priority patent/WO2019147931A1/en
Publication of JP2021511388A publication Critical patent/JP2021511388A/ja
Publication of JP2021511388A5 publication Critical patent/JP2021511388A5/ja
Application granted granted Critical
Publication of JP7369716B2 publication Critical patent/JP7369716B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020561603A 2018-01-26 2019-01-25 皮膚バリア機能を改善するためのアンブロキソールの使用 Active JP7369716B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862622375P 2018-01-26 2018-01-26
US62/622,375 2018-01-26
PCT/US2019/015137 WO2019147931A1 (en) 2018-01-26 2019-01-25 Use of ambroxol to improve skin barrier function

Publications (3)

Publication Number Publication Date
JP2021511388A JP2021511388A (ja) 2021-05-06
JP2021511388A5 true JP2021511388A5 (enExample) 2022-01-12
JP7369716B2 JP7369716B2 (ja) 2023-10-26

Family

ID=65363412

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020561603A Active JP7369716B2 (ja) 2018-01-26 2019-01-25 皮膚バリア機能を改善するためのアンブロキソールの使用

Country Status (6)

Country Link
US (3) US10894008B2 (enExample)
EP (1) EP3743039A1 (enExample)
JP (1) JP7369716B2 (enExample)
CN (1) CN111655223A (enExample)
CA (1) CA3087079A1 (enExample)
WO (1) WO2019147931A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3654960A1 (en) * 2017-07-16 2020-05-27 Neuere, LLC Ambroxol to improve and/or extend healthspan, lifespan and/or mental acuity
JP7369716B2 (ja) * 2018-01-26 2023-10-26 ノイレ, エルエルシー 皮膚バリア機能を改善するためのアンブロキソールの使用
WO2022098366A1 (en) * 2020-11-09 2022-05-12 Redwood Ip Holding, Llc Skincare compositions for preventing transepidermal water loss
JPWO2023145735A1 (enExample) * 2022-01-25 2023-08-03
KR20260002803A (ko) * 2023-05-02 2026-01-06 지위, 엘엘씨 치료적 사용을 위한 암브록솔의 변형된 형태

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69825495T2 (de) * 1998-12-23 2005-07-28 Idea Ag Verbesserte formulierung zur topischen, nichtinvasiven anwendung in vivo
MXPA04002066A (es) 2001-09-04 2005-02-17 Techno Network Shinoku Co Ltd Farmacos contra influenza.
DE10332487A1 (de) 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung von chronisch nozizeptiven Schmerzen
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
JP2008520630A (ja) * 2004-11-22 2008-06-19 シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト 皮膚損傷に有効なセラミド及び/又は偽セラミドと(α−)ビサボロールを含む製剤
EP2020988B1 (en) 2006-04-28 2017-08-16 Children's Hospital Medical Center Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems
US20080103207A1 (en) * 2006-08-09 2008-05-01 Takasago International Corp. (Usa) Topical ceramide compositions and methods of use
JP5337405B2 (ja) 2007-09-17 2013-11-06 ザ・ホスピタル・フォー・シック・チルドレン ゴーシェ病の治療方法
US20110294833A1 (en) 2010-05-26 2011-12-01 Scripps Health Methods for Healthy Aging
JP5938193B2 (ja) * 2011-11-10 2016-06-22 ポーラ化成工業株式会社 抗老化剤のスクリ−ニング方法
CN105708870A (zh) * 2011-11-30 2016-06-29 Ibr以色列生物科技研究有限公司 可用于改善皮肤屏障功能的荷荷巴提取物
JP2013241398A (ja) * 2012-04-27 2013-12-05 Fujifilm Corp β−グルコセレブロシダーゼ活性増強剤、セラミド産生増強剤及び皮膚バリア機能改善剤
TW201422246A (zh) * 2012-12-11 2014-06-16 Avon Prod Inc 藉由調節wipi-1改善皮膚老化外觀之方法
US20180296464A1 (en) 2017-04-17 2018-10-18 W Skincare, LLC Autophagy activation nutrient complex, compositions and methods
US10179095B2 (en) 2017-06-07 2019-01-15 Dr. Raymond Laboratories Autophage activating resveratrol topical composition for skin improvement and treatment
EP3654960A1 (en) * 2017-07-16 2020-05-27 Neuere, LLC Ambroxol to improve and/or extend healthspan, lifespan and/or mental acuity
JP7369716B2 (ja) * 2018-01-26 2023-10-26 ノイレ, エルエルシー 皮膚バリア機能を改善するためのアンブロキソールの使用

Similar Documents

Publication Publication Date Title
JP2021511388A5 (enExample)
US8845600B2 (en) Skin care compositions and uses thereof
AU2016202140B2 (en) Compositions for skin exfoliation and use thereof
EP3713583B1 (en) Methods and compositions for treatment of skin
TW201513853A (zh) 用於表皮修復和皮膚疾患治療的配方
HU218914B (hu) Eljárás cellulitis kezelésére alkalmas,hatóanyagként retinsavat vagy annak valamely sóját vagy retinolt tartalmazó gyógyszerkészítmények előállítására
JP4955382B2 (ja) 抗アレルギ作用及び抗炎症作用を有する表皮剥離性組成
JP2014521671A (ja) 皮膚および毛髪の外観を改善するためのスフィンガニンの使用
JP6842794B2 (ja) 皮膚外用製剤
KR20120118064A (ko) 염증후 과다색소침착의 감소로 비코카서스인 모집단에서의 여드름 치료를 위한 아다팔렌과 벤조일 퍼옥사이드의 조합물을 포함하는 피부용 조성물
CN106470677A (zh) 用于治疗皮肤学疾病及病症的组成物
US20200030398A1 (en) Skin care composition
US20020176876A1 (en) Topical therapeutic skin care system
KR20250163412A (ko) 스트론튬 및 메틸술포닐메탄(msm)을 포함하는 국소 제제 및 치료 방법
EP3195852B1 (en) Keratin softening patch
Vardy et al. A double-blind, placebo-controlled trial of a ciclopirox olamine 1% shampoo for the treatment of scalp seborrheic dermatitis
JP2013531664A (ja) Spf30を有する保湿組成物
RU2722823C2 (ru) Косметический состав для лечения и профилактики акне на коже
JP2016501236A (ja) 炎症性皮膚状態の予防および治療のための方法
JPH11505238A (ja) 皮膚症状処置用組成物
EP3378474B1 (en) Composition for the use in the treatment of plantar hyperhidrosis predisposing to cutaneous fungal infection of the foot
US20040204492A1 (en) Topical composition and method for treating seborrheic dermatitis
CN118973550A (zh) 用于局部使用以预防或治疗至少一种皮肤炎症症状的超支化糊精
SECTIO Etiopathogenesis and treatment of dry skin
JP2026506380A (ja) 皮膚の状態または疾患を処置する方法